Form 6-K Nanobiotix S.A. For: Dec 01
__________________________________________________________________________________
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
__________________________________________________________________________________
FORM 6-K
__________________________________________________________________________________
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934
December 1st, 2025
Commission File Number: 001-39777
__________________________________________________________________________________
NANOBIOTIX S.A.
(Translation of registrant’s name into English)
___________________________________________________________________________
60 rue de Wattignies 75012 Paris, France
(Address of principal executive offices)
__________________________________________________________________________________
1
INFORMATION CONTAINED IN THIS REPORT ON FORM 6-K
On December 1, 2025, Nanobiotix SA (the “Registrant”) provided notification and public disclosure of transactions by persons discharging managerial responsibilities (“PDMR”) and persons closely associated with them in accordance with the requirements of the EU Market Abuse Regulation (“MAR”), which are attached hereto as Exhibit 99.1.
EXHIBIT INDEX
Exhibit | Description | ||||
| 99.1 | |||||
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
NANOBIOTIX S.A.
Date: December 1, 2025 By: Laurent Levy, Chairman of the Executive Board
3
ATTACHMENTS / EXHIBITS
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Zeagoo x Maye Musk: Redefining Luxury Look for Prime Day
- Corgi Launches 35 ETFs on Cboe BZX - Including the Lowest-Cost Suite of 2x Daily ETFs on the Market
- TrendAI™ Joins Anthropic's Project Glasswing
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share